With only a few weeks to go until the 7th CAR-TCR Summit Europe, we caught up with Ali Mohamed, PhD, Senior Vice President of CMC and Immatics to gain some early insights! View the full interview now: https://ter.li/ni8c62 Discover Ali's thoughts on: 🚧 What are the major hurdles that remain in cell therapy manufacturing? 🚀 Why are next-gen advances so important in the cell therapy space? 🎢 How can platforms like this help address these challenges and accelerate next gen advances? #CARTCR
CAR-TCR Summit Series’ Post
More Relevant Posts
-
Gain valuable insights from cell therapy experts on CAR detection advancements, current challenges in CAR-T and CAR-NK therapy development, and exciting innovations on the horizon. Learn more here: https://bit.ly/3X3ELkI
To view or add a comment, sign in
-
-
#Interview now available! Tracking current and predicting future cell therapy #analyticaltoolkit evolution With #celltherapy technologies and modalities entering the clinic and the marketplace, the industry’s focus remains fixed on delivering an analytical toolkit capable of adequately characterizing these novel products. In this article, Namyong Kim (CEO, Curiox Biosystems) explores technological breakthroughs that could deliver the requisite improvements in speed, accuracy, consistency, and sensitivity. Read below:
To view or add a comment, sign in
-
Discovery Medical Sales Account Manager at Cytiva | Boston West & South | Platinum Sales Club-Rookie of the Year Award 2020
What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/eAgJhEb9
To view or add a comment, sign in
-
🔬 Driving Breakthroughs in Molecular Interaction Analysis | Empowering Life Science Discoveries with Label-Free Technology | 🧪 🧬
What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/gfekuwwE
To view or add a comment, sign in
-
What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/e-SfFMrh
To view or add a comment, sign in
-
What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/eeAnib5g
To view or add a comment, sign in
-
Dive into the dynamic world of cell therapy with the release of the first part of our 2023 Landscape Review Series! Uncover the latest trends, challenges, and innovations that shaped the drug landscape. Download your copy now! https://ter.li/rzt2xj #CellTherapy #LandscapeReview
To view or add a comment, sign in
-
-
What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/eguyXjtE
To view or add a comment, sign in
-
What are the four major pain points in cell therapy manufacturing scale-up? In this clip, Dawn Maier from ElevateBio identifies one — labor costs. Watch the full episode to learn about the others. https://lnkd.in/dmU7cTAd
To view or add a comment, sign in